🟢 Sionna Therapeutics is trading 5% up today amid biotech-sector strength

Sionna Therapeutics is trading 5.4% higher at $4.10 on October 19, 2026, in a move that appears consistent with biotech-sector strength.

• The supplied sector context shows XBI up 2.09%.
• No company-specific announcement explaining the move was identified; the company’s latest listed news release was dated October 8.
• Merck KGaA agreed to acquire Silence Therapeutics for approximately $1.3 billion; the deal is not specific to Sionna.